Addus HomeCare (NASDAQ:ADUS) Given Market Outperform Rating at JMP Securities

JMP Securities reaffirmed their market outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a research note issued to investors on Tuesday morning,Benzinga reports. JMP Securities currently has a $150.00 target price on the stock.

ADUS has been the topic of several other research reports. Oppenheimer raised their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Macquarie reiterated an “outperform” rating and issued a $129.00 price target on shares of Addus HomeCare in a research report on Thursday, February 27th. Stephens reaffirmed an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. Finally, StockNews.com lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $132.78.

Addus HomeCare Stock Performance

Addus HomeCare stock opened at $98.04 on Tuesday. The stock has a market cap of $1.78 billion, a price-to-earnings ratio of 22.43, a PEG ratio of 1.41 and a beta of 0.93. The stock’s 50 day simple moving average is $98.76 and its two-hundred day simple moving average is $116.65. Addus HomeCare has a fifty-two week low of $87.88 and a fifty-two week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. On average, analysts predict that Addus HomeCare will post 4.59 earnings per share for the current year.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds have recently bought and sold shares of the stock. Capital Research Global Investors purchased a new stake in shares of Addus HomeCare during the fourth quarter worth approximately $51,149,000. American Century Companies Inc. raised its holdings in shares of Addus HomeCare by 695.8% in the 4th quarter. American Century Companies Inc. now owns 284,346 shares of the company’s stock valued at $35,643,000 after purchasing an additional 248,613 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Addus HomeCare by 10,307.8% during the 1st quarter. GAMMA Investing LLC now owns 130,930 shares of the company’s stock worth $12,948,000 after purchasing an additional 129,672 shares during the last quarter. Bank of America Corp DE grew its stake in shares of Addus HomeCare by 273.6% during the fourth quarter. Bank of America Corp DE now owns 175,070 shares of the company’s stock worth $21,945,000 after purchasing an additional 128,211 shares in the last quarter. Finally, TimesSquare Capital Management LLC raised its position in shares of Addus HomeCare by 28.5% during the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock worth $44,593,000 after acquiring an additional 78,835 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.